Upcoming Earnings: Q2 '26
Estimated EPS
$0.24
Estimated Rev
$96.04M
$CRMD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.48 up 50.00% YoY • Reported revenue of $127.43M up 226.05% YoY • CorMedix increased its full-year 2026 net revenue guidance to a range of $325M to $345M and adjusted EBITDA guidance to a range of $115M to $135M.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | $0.24 | -- | -- | N/A |
Q1 '26 | $0.34 | $0.43 | 25.42% | BEAT |
Q4 '25 | $0.82 | $0.16 | -80.40% | MISSED |
Q3 '25 | $0.63 | $1.26 | 98.65% | BEAT |
Q2 '25 | $0.19 | $0.29 | 54.96% | BEAT |



